Treatment OutcomeOutcome Assessment (Health Care)Retrospective StudiesQuality Indicators, Health CarePrognosisPregnancy OutcomeFollow-Up StudiesProspective StudiesAntitubercular AgentsTime FactorsOutcome and Process Assessment (Health Care)Risk FactorsCohort StudiesDirectly Observed TherapyCognitive TherapySurvival AnalysisPredictive Value of TestsSeverity of Illness IndexTreatment FailureSurvival RateRecurrenceCombined Modality TherapyPatient ComplianceTuberculosis, PulmonaryPregnancyHealth Status IndicatorsExtensively Drug-Resistant TuberculosisMultivariate AnalysisTuberculosis, Multidrug-ResistantInfant, NewbornRandomized Controlled Trials as TopicLogistic ModelsAge FactorsKaplan-Meier EstimateQuality of LifeSubstance-Related DisordersBuprenorphineHIV InfectionsUnited StatesOpioid-Related DisordersNeoplasm StagingPsychotherapyRisk AssessmentSubstance Abuse Treatment CentersAlcoholismPatient SatisfactionDrug Therapy, CombinationReproducibility of ResultsTuberculosisHospitals, Chronic DiseaseTemperanceRegression AnalysisAntineoplastic Combined Chemotherapy ProtocolsPsychiatric Status Rating ScalesLongitudinal StudiesDisease-Free SurvivalIndicators and ReagentsRemission InductionBiological MarkersProportional Hazards ModelsPatient DropoutsPostoperative ComplicationsSex FactorsImplosive TherapyAnalysis of VarianceChi-Square DistributionCocaine-Related DisordersIncidenceDepressive Disorder, MajorMethadoneDisease ProgressionClinical Trials as TopicResearch DesignCross-Sectional StudiesGenotypeSocioeconomic FactorsAnti-Retroviral AgentsResidential TreatmentRetreatmentPilot ProjectsNeoplasm Recurrence, LocalMedication AdherenceCoinfectionPrevalenceEthambutolRegistriesBehavior TherapyAnti-HIV AgentsAcute DiseaseStatistics, NonparametricSensitivity and SpecificityQuestionnairesPatient SelectionPrecursor Cell Lymphoblastic Leukemia-LymphomaLength of StayChronic DiseasePeer Review, Health CareAntidepressive AgentsRibavirinOdds Ratio